Skip to main content

Sustainable production of transgenic strawberry plants. ethnical consequences and potential effect on the producers and consumers.

Objective

The rationale for this project is given by the fact that the pharmaceutical industry is currently undergoing a significant change in strategy in preclinical drug development. Relevant advances are being made in the field of genome analysis with the onset of gene chip technologies permitting high throughput investigations and the use of miniature sample quantities. The same is happening for protease analysis and mass- spectrometry. We want to develop the "missing link" in high throughput testing: A highly controlled high-throughput bioreactor based on the use of engineered miniature in vitro tissue analogues. This will lead to the establishment of a firm correlation between genome, protease and catalytic expressions or biochemical function resulting in a complementary and more predictive picture of drug action.

Funding Scheme

CSC - Cost-sharing contracts

Coordinator

NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY
Address
Ntnu
7491 Trondheim
Norway

Participants (2)

AACHEN UNIVERSITY OF TECHNOLOGY
Germany
Address
Eilfshornstrasse, 16
52056 Aachen
CENTRE FOR RURAL RESEARCH
Norway
Address
University Centre, Ntnu Dragvoll
7491 Trondheim